{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:29:53Z","timestamp":1789576193263,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clon.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T08:33:27Z","timestamp":1620635607000},"page":"591-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?"],"prefix":"10.1016","volume":"33","author":[{"given":"D.C.R.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.N.","family":"Andreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clon.2021.04.009_bib1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(07)70341-8","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients","volume":"8","author":"Andreyev","year":"2007","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0360-3016(02)02808-0","article-title":"Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer","volume":"53","author":"Hovdenak","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/02841860601099241","article-title":"Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy","volume":"46","author":"Larsen","year":"2007","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/COC.0000000000000268","article-title":"Smoking decreases survival in locally advanced cervical cancer treated with radiation","volume":"41","author":"Mayadev","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"Spec No 1","key":"10.1016\/j.clon.2021.04.009_bib5","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1259\/bjr\/33057885","article-title":"Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury","volume":"80","author":"Wang","year":"2007","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0360-3016(01)01556-5","article-title":"Is it time for a new formalism to categorize normal tissue radiation injury?","volume":"50","author":"Denham","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0360-3016(83)90316-4","article-title":"The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix","volume":"9","author":"Bourne","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/02841868809090339","article-title":"Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies","volume":"27","author":"Peters","year":"1988","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.clon.2021.04.009_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrgastro.2014.46","article-title":"Radiation enteropathy \u2013pathogenesis, treatment and prevention","volume":"11","author":"Hauer-Jensen","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00365521.2010.545832","article-title":"\u201cPelvic radiation disease\u201d: new understanding and new solutions for a new disease in the era of cancer survivorship","volume":"46","author":"Andreyev","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib11","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S1470-2045(13)70504-7","article-title":"Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist","volume":"15","author":"Ferreira","year":"2014","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.clon.2021.04.009_bib12","doi-asserted-by":"crossref","first-page":"1901048","DOI":"10.1002\/advs.201901048","article-title":"Sexual dimorphism of gut microbiota dictates therapeutics efficacy of radiation injuries","volume":"6","author":"Cui","year":"2019","journal-title":"Adv Sci"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2019.09.002","article-title":"Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls","volume":"155","author":"Sims","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2019.12.040","article-title":"Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer","volume":"107","author":"Mitra","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib15","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/jcmm.14289","article-title":"Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy","volume":"23","author":"Wang","year":"2019","journal-title":"J\u00a0Cell Mol Med"},{"issue":"12","key":"10.1016\/j.clon.2021.04.009_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082659","article-title":"Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing","volume":"8","author":"Nam","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.clon.2021.04.009_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1572-0241.2008.01868.x","article-title":"The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea","volume":"103","author":"Manichanh","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib18","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.clon.2021.04.009_bib20","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00054725-201112002-00286","article-title":"Radiation exposure induces dysbioses throughout the small intestinal and colonic lumen and mucosa that resemble those seen in human inflammatory bowel diseases","volume":"17","author":"Bowen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"20","key":"10.1016\/j.clon.2021.04.009_bib21","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","article-title":"Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease","volume":"13","author":"Tedelind","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.clon.2021.04.009_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","article-title":"Microbial butyrate and its role for barrier function in the gastrointestinal tract","volume":"1258","author":"Ploger","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ecl.2008.08.006","article-title":"The microbes of the intestine: an introduction to their metabolic and signaling capabilities","volume":"37","author":"Hsiao","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.clon.2021.04.009_bib26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00066-008-1896-1","article-title":"Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation","volume":"184","author":"Hille","year":"2008","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/17474124.2019.1595586","article-title":"Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis","volume":"13","author":"Al-Qadami","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ijrobp.2004.12.087","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?","volume":"62","author":"Andreyev","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.clon.2021.04.009_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","article-title":"Gastrointestinal complications of pelvic radiotherapy: are they of any importance?","volume":"54","author":"Andreyev","year":"2005","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib31","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2003.05.060","article-title":"Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy","volume":"21","author":"Kozelsky","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11764-015-0472-9","article-title":"Survivors of gynecologic malignancies: impact of treatment on health and well-being","volume":"10","author":"Westin","year":"2016","journal-title":"J\u00a0Canc Surviv"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","article-title":"A\u00a0systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer","volume":"68","author":"Kirwan","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2021.04.009_bib34","first-page":"CD010870","article-title":"Surgical treatment of stage IA2 cervical cancer","volume":"5","author":"Kokka","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0360-3016(86)90279-8","article-title":"A\u00a0prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation","volume":"12","author":"Gallagher","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib36","first-page":"117","article-title":"Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond","volume":"55","author":"Bucci","year":"2005","journal-title":"CA Canc J Clin"},{"issue":"11 Suppl. 2","key":"10.1016\/j.clon.2021.04.009_bib37","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1111\/IGC.0b013e3181f7b241","article-title":"Modern radiotherapy and cervical cancer","volume":"20","author":"Powell","year":"2010","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","article-title":"Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis","volume":"13","author":"Lin","year":"2018","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cncr.10248","article-title":"The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients","volume":"94","author":"Bacon","year":"2002","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.clon.2007.08.011","article-title":"Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future","volume":"19","author":"Andreyev","year":"2007","journal-title":"Clin Oncol"},{"issue":"7","key":"10.1016\/j.clon.2021.04.009_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.6004\/jnccn.2013.0103","article-title":"The case for including bowel urgency in toxicity reporting after pelvic cancer treatment","volume":"11","author":"Henson","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clon.2021.04.009_bib42","first-page":"158","article-title":"\u2018Just grin and bear it and hope that it will go away\u2019: coping with urinary symptoms from pelvic radiotherapy","volume":"4","author":"Faithfull","year":"1995","journal-title":"Eur J Canc Care"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1365-2036.2003.01760.x","article-title":"How patients manage gastrointestinal symptoms after pelvic radiotherapy","volume":"18","author":"Gami","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib44","first-page":"278","article-title":"Patient-reported outcomes in cancer: a review of recent research and policy initiatives","volume":"57","author":"Lipscomb","year":"2007","journal-title":"CA Canc J Clin"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Canc Inst"},{"key":"10.1016\/j.clon.2021.04.009_bib46","first-page":"1","article-title":"Cancer outcomes research and the arenas of application","volume":"33","author":"Lipscomb","year":"2004","journal-title":"J\u00a0Natl Canc Inst Monogr"},{"issue":"7","key":"10.1016\/j.clon.2021.04.009_bib47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.2011.339","article-title":"Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?","volume":"105","author":"White","year":"2011","journal-title":"Br J Canc"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clon.2013.08.003","article-title":"The effects of pelvic radiotherapy on cancer survivors: symptom profile, psychological morbidity and quality of life","volume":"26","author":"Adams","year":"2014","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11136-017-1700-8","article-title":"Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer","volume":"27","author":"Tom","year":"2018","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.radonc.2008.09.019","article-title":"Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial","volume":"90","author":"Capp","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2014.11.071","article-title":"Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic","volume":"136","author":"Gilbert","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib52","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.clon.2016.06.004","article-title":"The three-item ALERT-B questionnaire provides a validated screening tool to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors","volume":"28","author":"Taylor","year":"2016","journal-title":"Clin Oncol"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.44.1.77","article-title":"Prospective comparison of faecal incontinence grading systems","volume":"44","author":"Vaizey","year":"1999","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7861\/clinmedicine.16-3-240","article-title":"The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?","volume":"16","author":"Muls","year":"2016","journal-title":"Clin Med"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/0284186X.2013.873140","article-title":"Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling","volume":"53","author":"Muls","year":"2014","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib57","article-title":"Clinical decision-making in managing changes in gastrointestinal function following cancer therapies: is experience enough?","volume":"27","author":"Muls","year":"2018","journal-title":"Eur J Canc Care (Engl)"},{"issue":"9910","key":"10.1016\/j.clon.2021.04.009_bib58","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(13)61648-7","article-title":"Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial","volume":"382","author":"Andreyev","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib59","first-page":"2881","article-title":"Outcomes from treating bile acid malabsorption using a multidisciplinary approach","volume":"23","author":"Gupta","year":"2015","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.clon.2021.04.009_bib60","first-page":"2255","article-title":"Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy","volume":"21","author":"Henson","year":"2013","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/flgastro-2014-100468","article-title":"Guidance: the practical management of the gastrointestinal symptoms of pelvic radiation disease","volume":"6","author":"Andreyev","year":"2015","journal-title":"Frontline Gastroenterol"},{"issue":"41","key":"10.1016\/j.clon.2021.04.009_bib62","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.3748\/wjg.v25.i41.6172","article-title":"Disease monitoring strategies in inflammatory bowel diseases: what do we mean by \u201ctight control\u201d?","volume":"25","author":"Gonczi","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clon.2021.04.009_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"J\u00a0Inflamm Res"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10555-008-9138-7","article-title":"Molecular markers of radiation-related normal tissue toxicity","volume":"27","author":"Okunieff","year":"2008","journal-title":"Canc Metastasis Rev"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/09553002.2017.1338782","volume":"93","author":"Singh","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.clon.2021.04.009_bib66","series-title":"Undersea Hyperb Med","first-page":"4","article-title":"A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach","volume":"vol. 29","author":"Feldmeier","year":"2002"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.28920\/dhm50.3.250-255","article-title":"An observational trial to establish the effect of hyperbaric oxygen treatment on pelvic late radiation tissue injury due to radiotherapy","volume":"50","author":"Andren","year":"2020","journal-title":"Diving Hyperb Med"},{"key":"10.1016\/j.clon.2021.04.009_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fonc.2020.00390","article-title":"The effects of hyperbaric oxygen therapy on pelvic radiation induced gastrointestinal complications (rectal bleeding, diarrhea, and pain): a meta-analysis","volume":"10","author":"Yuan","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2021.04.009_bib69","article-title":"Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy","volume":"3","author":"Pareek","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clon.2021.04.009_bib70","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.nut.2014.08.007","article-title":"Vitamin E therapy for NAFLD\/NASH","volume":"31","author":"Yoneda","year":"2015","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12032-019-1334-5","article-title":"Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study","volume":"37","author":"Sayed","year":"2019","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12032-007-0006-z","article-title":"Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer","volume":"24","author":"Misirlioglu","year":"2007","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib73","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ijrobp.2012.06.042","article-title":"Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter","volume":"85","author":"Jacobson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0360-3016(89)90376-3","article-title":"The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice","volume":"17","author":"Dion","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00005537-199703000-00022","article-title":"Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations","volume":"107","author":"Futran","year":"1997","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0360-3016(94)E0307-6","article-title":"Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats","volume":"31","author":"Koh","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib77","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0360-3016(90)90549-Y","article-title":"Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis","volume":"19","author":"Dion","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10.1016\/j.clon.2021.04.009_bib78","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1200\/JCO.2005.02.4729","article-title":"Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis","volume":"23","author":"Delanian","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib79","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1345\/aph.1E186","article-title":"Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis","volume":"39","author":"Chiao","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib81","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1200\/JCO.1999.17.10.3283","article-title":"Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol","volume":"17","author":"Delanian","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2004.09.013","article-title":"Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer","volume":"73","author":"Gothard","year":"2004","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib83","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.radonc.2005.09.014","article-title":"Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial","volume":"77","author":"Haddad","year":"2005","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib84","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.radonc.2005.02.002","article-title":"Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy","volume":"75","author":"Gothard","year":"2005","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.clon.2021.04.009_bib85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00066-005-1390-y","article-title":"Effect of pentoxifylline and tocopherol on radiation proctitis\/enteritis","volume":"181","author":"Hille","year":"2005","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"10.1016\/j.clon.2021.04.009_bib86","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000163557","article-title":"Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study","volume":"86","author":"Williamson","year":"2008","journal-title":"Stereotact Funct Neurosurg"},{"issue":"14","key":"10.1016\/j.clon.2021.04.009_bib87","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.ejca.2009.05.015","article-title":"Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)","volume":"45","author":"Magnusson","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.08.023","article-title":"Radiation-induced enteropathy: molecular basis of pentoxifylline-vitamin E anti-fibrotic effect involved TGF-\u03b21 cascade inhibition","volume":"105","author":"Hamama","year":"2012","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib89","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bjoms.2014.01.003","article-title":"Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit","volume":"52","author":"D'Souza","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.clon.2021.04.009_bib90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/scd.12124","article-title":"The efficacy of pentoxifylline\/tocopherol combination in the treatment of osteoradionecrosis","volume":"35","author":"Hayashi","year":"2015","journal-title":"Spec Care Dentist"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib91","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bjoms.2015.11.027","article-title":"Use of pentoxifylline and tocopherol in the management of osteoradionecrosis","volume":"54","author":"Patel","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.clon.2021.04.009_bib92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.clon.2015.06.010","article-title":"Prevention and management of radiation-induced late gastrointestinal toxicity","volume":"27","author":"Teo","year":"2015","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib93","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0029665118000101","article-title":"Nutritional strategies to prevent gastrointestinal toxicity during pelvic radiotherapy","volume":"77","author":"Wedlake","year":"2018","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0009-9260(80)80075-4","article-title":"Clinical observations on the effects of elemental diet supplementation during irradiation","volume":"31","author":"Brown","year":"1980","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clon.2021.04.009_bib95","first-page":"S44","article-title":"Diet prevention of radiation acute enteric toxicity: multicentric randomised study","volume":"56","author":"Capirci","year":"2000","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.clon.2021.04.009_bib96","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1365-2036.2008.03665.x","article-title":"Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy","volume":"27","author":"McGough","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-9260(80)80073-0","article-title":"The metabolic effects of abdominal irradiation in man with and without dietary therapy with an elemental diet","volume":"31","author":"Foster","year":"1980","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0261-5614(95)80004-2","article-title":"Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease","volume":"14","author":"Middleton","year":"1995","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.clon.2021.04.009_bib99","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0360-3016(84)90267-0","article-title":"A\u00a0clinical trial evaluating cholestyramine to prevent diarrhea in patients maintained on low-fat diets during pelvic radiation therapy","volume":"10","author":"Chary","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/02841867909128231","article-title":"Effect of a low-fat diet on bile salt excretion and diarrhoea in the gastrointestinal radiation syndrome","volume":"18","author":"Bosaeus","year":"1979","journal-title":"Acta Radiol Oncol Radiat Phys Biol"},{"issue":"5","key":"10.1016\/j.clon.2021.04.009_bib101","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1475-097X.2002.00435.x","article-title":"The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion","volume":"22","author":"Symersky","year":"2002","journal-title":"Clin Physiol Funct Imaging"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0261-5614(92)90075-2","article-title":"The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy","volume":"11","author":"Bye","year":"1992","journal-title":"Clin Nutr"},{"issue":"Special Supplemt","key":"10.1016\/j.clon.2021.04.009_bib103","first-page":"39","article-title":"A randomised trial with low fat diets to improve food intake and tolerance in women receiving abdominal radiotherapy for cancer","volume":"8","author":"Karlson","year":"1989","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clon.2021.04.009_bib104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-277X.2012.01248.x","article-title":"Clinical trial: efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies","volume":"25","author":"Wedlake","year":"2012","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"2","key":"10.1016\/j.clon.2021.04.009_bib105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jand.2020.08.077","article-title":"The efficacy of dietary fiber in managing gastrointestinal toxicity symptoms in patients with gynecologic cancers undergoing pelvic radiotherapy: a systematic review","volume":"121","author":"Croisier","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clon.2021.04.009_bib106","first-page":"CD012529","article-title":"Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers","volume":"1","author":"Lawrie","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2021.04.009_bib107","first-page":"2","article-title":"Space radiation protection: destination Mars","volume":"1","author":"Durante","year":"2014","journal-title":"Life Sci Space Res"},{"issue":"1","key":"10.1016\/j.clon.2021.04.009_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09553002.2019.1640043","article-title":"Non-clinical radiation biology and pharmacology models: appraisal of state-of-the-art and innovation","volume":"96","author":"Authier","year":"2020","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"10.1016\/j.clon.2021.04.009_bib109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1667\/RR14272.1","article-title":"GI consequences of cancer treatment: a clinical perspective","volume":"185","author":"Andreyev","year":"2016","journal-title":"Radiat Res"},{"issue":"648","key":"10.1016\/j.clon.2021.04.009_bib110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3399\/bjgp16X685789","article-title":"Managing the consequences of cancer in primary care","volume":"66","author":"Linden","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.clon.2021.04.009_bib111","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s11764-016-0545-4","article-title":"The role of the GP in follow-up cancer care: a systematic literature review","volume":"10","author":"Meiklejohn","year":"2016","journal-title":"J\u00a0Canc Surviv"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655521001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655521001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:49:38Z","timestamp":1760543378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655521001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0936655521001667"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2021.04.009","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}